Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy

被引:0
|
作者
ZHANG Bo LIU Zhihong ZENG Caihong ZHENG Jingmin CHEN Huiping ZHOU Hong and LI LeishiResearch Institute of Nephrology Jingling Hospital Nanjing University School of Medicine Nanjing ChinaDepartment of Nephrology First Affiliated Hospital of Nanjing Medical University Nanjing China [210002 ,210029 ]
机构
关键词
D O I
暂无
中图分类号
R692 [肾疾病];
学科分类号
摘要
Background Lipoprotein glomerulopathy (LPG) is a renal disease characterized by thrombus-like lipoproteins in the glomerular capillaries and its abnormal lipoprotein profiles with marked elevation of apolipoprotein E (apoE). In this study, 15 Chinese patients with LPG were involed in exploring the association of the genetic variation and its plasma level in the pathogenesis of LPG.Methods A retrospective analysis of the clinical and pathological features was made in 15 patients with LPG. Plasma concentrations of apoE were measured with radial immunodiffusion assay. Genetic variations of apoE gene were detected using polymerase chain reaction and restriction fragment length polymorphism. Glomerular deposition of apoA, apoB and apoE in these patients were detected by immunofluorescence staining using monoclonal antibodies. Results Biochemical profiles of lipids and lipoproteins revealed markedly elevated levels of triglyceride, apoB and apoE, but approximately normal levels of total cholesterol, apoA1 and lipoprotein(a) [Lp(a)], which resembled familial hypertriglyceridemia. Genetic analysis demonstrated that the genotype distribution of apoE were 7 cases with (ε3/ε 4,)4 cases with ε3/ε 3 and 2 cases with ε2/ε 3. The other 2 cases (a mother and her son) showed a same distinct band. The band pattern of later 2 cases was quite similar to the apoE variant of Tokyo type. The calculated allele frequency of ε 4 was relatively high in cases with LPG in comparison with that in the normal controls. We further divided the 13 patients into three groups according to their genotypes of apoE. Patients with the genotype of apoE ε2/ε3 showed a lower level of plasma apoE as compared to those with apoE ε3/ε4 (P<0.05). The serum level of high-density lipoprotein (HDL) was the lowest in patients with the genotype of apoE ε3/ε4. No difference was found among the patients with different apoE genotype in the other clinical and pathological characteristics. Conclusions The genotype of apoE ε3/ε4 is the predominant one in Chinese patients with LPG. Patients with this genotype tend to have a higher plasma level of apoE and more severe lipid dysmetabolism. No correlation was found between the genotype of apoE and the clinical features in patients with LPG.
引用
收藏
页码:555 / 560
页数:6
相关论文
共 50 条
  • [21] Significance of a Novel Apolipoprotein E Variant, ApoE Osaka/Kurashiki, in Lipoprotein Glomerulopathy
    Saito, Takao
    Matsunaga, Akira
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011, 18 (06) : 542 - 543
  • [22] Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia
    Matsunaga, Akira
    Saito, Takao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (02) : 220 - 224
  • [23] Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia
    Akira Matsunaga
    Takao Saito
    Clinical and Experimental Nephrology, 2014, 18 : 220 - 224
  • [24] Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients
    Eggertsen, G
    Heimburger, O
    Stenvinkel, P
    Berglund, L
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (01) : 141 - 144
  • [25] Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy
    Zhang, Bo
    Liu, Zhi-Hong
    Zeng, Cai-Hong
    Zheng, Jing-Min
    Chen, Hui-Ping
    Li, Lei-Shi
    JOURNAL OF NEPHROLOGY, 2008, 21 (01) : 110 - 117
  • [26] A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy
    Ando, M
    Sasaki, J
    Hua, H
    Matsunaga, A
    Uchida, K
    Jou, K
    Oikawa, S
    Saito, T
    Nihei, H
    KIDNEY INTERNATIONAL, 1999, 56 (04) : 1317 - 1323
  • [27] A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I
    Satoshi Takasaki
    Akira Matsunaga
    Kensuke Joh
    Takao Saito
    CEN Case Reports, 2018, 7 (1) : 127 - 131
  • [28] A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy
    Hagiwara, Masahiro
    Yamagata, Kunihiro
    Matsunaga, Tsuneaki
    Arakawa, Yoh
    Usui, Joichi
    Shimizu, Yoshio
    Aita, Kumi
    Nagata, Michio
    Koyama, Akio
    Zhang, Bo
    Mastunaga, Akira
    Saku, Keigiro
    Saito, Takao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (01) : 381 - 384
  • [29] A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I
    Takasaki, Satoshi
    Matsunaga, Akira
    Joh, Kensuke
    Saito, Takao
    CEN CASE REPORTS, 2018, 7 (01): : 127 - 131
  • [30] APOLIPOPROTEIN-E GENOTYPE AND PLASMA-LIPOPROTEIN VARIATION IN THE KEEWATIN-INUIT OF CANADA
    HEGELE, RA
    WONG, M
    YOUNG, TK
    CONNELLY, PW
    CIRCULATION, 1995, 92 (08) : 1192 - 1192